PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Agree. If they set out a clear pathway that isn't too onerous on...

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    Agree. If they set out a clear pathway that isn't too onerous on 002-3 its a very big tick for PAR.

    Duration in effective pain relief will also be massive to BP so it may not take much more convincing post the release of 365 day data points (plus MRI) to strike a discrete regional deal acceptable to both parties.

    IMO the market sentiment seems overly focused on the short term. The next release may confirm just how badly the market has judged PAR's long term prospects.






    Last edited by Denial: 28/09/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.